Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 131-141
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 020-047
Open Access | Times Cited: 363
ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Journal of Arrhythmia (2021) Vol. 37, Iss. 6, pp. 1389-1426
Open Access | Times Cited: 66
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 7, pp. 677-686
Open Access | Times Cited: 65
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Parham Sadeghipour, Behnood Bikdeli, Azita H. Talasaz, et al.
BMJ (2022), pp. e068407-e068407
Open Access | Times Cited: 65
Anticoagulants for people hospitalised with COVID-19
Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, Jéssica Dantas de Sá Tinôco, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 50
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Preferences for thromboprophylaxis in the intensive care unit: An international survey
Èmese Heijkoop, Frederik Keus, Morten Hylander Møller, et al.
Acta Anaesthesiologica Scandinavica (2025) Vol. 69, Iss. 4
Open Access
Anticoagulation in ECMO: Target Values to Reduce Hemorrhagic Complications in Adults. A Retrospective Cohort Study
Jenny Paola Garzón Ruiz, Estefanía Giraldo Bejarano, Mario Andrés Mercado Díaz, et al.
ASAIO Journal (2025)
Closed Access
Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial
Nuccia Morici, Gian Marco Podda, Simone Birocchi, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 5
Closed Access | Times Cited: 37
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis
Matteo Candeloro, Sam Schulman
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 047-054
Open Access | Times Cited: 24
Thrombosis and Haemostasis 2022 Editors' Choice Papers
Christian Weber, Xavier Blanchet, Gregory Y.H. Lip
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 01, pp. 123-130
Closed Access | Times Cited: 14
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102031-102031
Open Access | Times Cited: 13
The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 2, pp. 257-265
Open Access | Times Cited: 27
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Maria Popp, Selina Schießer, et al.
Thrombosis Research (2022) Vol. 219, pp. 40-48
Open Access | Times Cited: 20
Step up to the platelet: Role of platelets in inflammation and infection
Agostina Carestia, Laura C. Godin, Craig N. Jenne
Thrombosis Research (2022) Vol. 231, pp. 182-194
Closed Access | Times Cited: 20
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Sirui Zhang, Yupei Li, Guina Liu, et al.
Thrombosis Journal (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 23
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
Andrea Spini, Valentina Giudice, Vincenzo Brancaleone, et al.
Pharmacological Research (2021) Vol. 173, pp. 105848-105848
Open Access | Times Cited: 22
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis
Xinwang Chen, Suyun Zhang, Haiyu Liu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Thromboinflammation and Antithrombotics in COVID-19
Jean M. Connors, Paul M. Ridker
JAMA (2022) Vol. 327, Iss. 13, pp. 1234-1234
Open Access | Times Cited: 13
Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue
Valentin Varlas, Roxana Georgiana Borş, Mihaela Plotogea, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1949-1949
Open Access | Times Cited: 7
Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis
Stefanie Reis, Maria Popp, Benedikt Schmid, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 57-57
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top